Ind-Swift Laboratories has target of Rs 150: Gujral

2278 Investors following Ind-Swift Labs. Share this News with them.

0

Like this story, share it with millions of investors on M3

Ind-Swift Laboratories has target of Rs 150: Gujral

Ind-Swift Laboratories has target of Rs 150, says Technical Analyst, Ashwani Gujral.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Power Breakfast on CNBC-TV18 Watch the full show » ALSO READ See previous views by Ashwani Gujral See what other Experts & Brokerages are saying about Ind-Swift Labs See messages about Ind-Swift Labs

Ind-Swift Laboratories has target of Rs 150, says Technical Analyst, Ashwani Gujral .

Gujral told CNBC-TV18, "Generally when markets become sideways, healthcare tends to do better. Ind-Swift Laboratories also moved sideways for a long time and now has broken out; a short-term target here could be closer to Rs 150."

Ind-Swift Laboratories trailing 12-month (TTM) EPS was at Rs 21.00 per share. (Jun, 2010). The stock's price-to-earnings  (P/E) ratio was 6.61. The latest book value of the company is Rs 110.98 per share. At current value, the price-to-book value of the company was 1.25. The dividend yield of the company was 0.72%.